What is the EMA's approach to emerging toxicological concerns?
The EMA actively addresses emerging toxicological concerns by staying abreast of the latest scientific developments and potential threats to public health. For instance, the EMA has developed strategies to assess the safety of nanomedicines and other advanced therapies, which may present unique toxicological challenges. The agency also collaborates with international regulatory bodies to harmonize approaches to emerging risks, ensuring a coordinated response to global health challenges.
